Rozanolixizumab improved muscle weakness and fatigue in myasthenia gravis patients, as shown in the MycarinG study using MG Symptoms PRO scales. Strong correlations were found between MG Symptoms PRO ...
Today, AG1, a leading global health company, announced the launch of its latest product, AG1 Pro. Built on the clinically-backed formula of AG1 Next Gen, AG1 Pro features additional research-backed ...
The exponential rise of our aging population. The pandemic. The explosion of GLP-1s. It’s a trifecta that’s making muscle — and the serious implications of not having enough of it — part of a larger ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results